Form 4: Major Shareholder Era Regenerative Medicine Boosts Stake in REED'S, INC. Through PIPE Transaction

Era Regenerative Medicine Ltd., a significant shareholder and director, has increased its beneficial ownership in REED'S, INC. by acquiring over 1 million shares through a private investment in public equity (PIPE) transaction.

Summary

• Era Regenerative Medicine Ltd. and D&D Source of Life Holding Ltd. reported an acquisition of 1,075,269 shares of REED'S, INC. common stock.
• The transaction occurred on June 4, 2025, at a purchase price of $0.93 per share.
• Following this acquisition, the reporting persons beneficially own a total of 28,214,789 shares of common stock, which includes 232,108 shares issuable upon exercise of currently exercisable warrants.
• The acquisition was part of the Registrant's Private Investment in Public Equity (PIPE) transaction.
• Era Regenerative Medicine Ltd. holds all shares in D&D Source of Life Holding Ltd., and Dai Siqi, as the sole director of Era Regenerative Medicine Ltd., has sole voting and dispositive power over these securities.

Sentiment

Score: 8

Explanation: The significant insider purchase by a major shareholder and director, coupled with participation in a PIPE transaction, indicates strong confidence and a positive outlook for the company.

Positives

• A significant increase in beneficial ownership by a major shareholder and director, indicating strong insider confidence in the company's future.
• Participation in a PIPE transaction suggests a strategic investment and potential long-term commitment from the investor.
• The acquisition price of $0.93 per share provides a clear valuation point for this significant investment.

Future Outlook

NA

Management Comments

• Dai Siqi disclaims beneficial ownership in the securities of the Registrant except for his pecuniary interest therein as sole director of Era Regenerative Medicine Ltd.

Industry Context

NA

Related Party Transactions

• The acquisition of shares by Era Regenerative Medicine Ltd. and D&D Source of Life Holding Ltd. is considered a related party transaction, as both entities are 10% owners and directors of REED'S, INC.

Stakeholder Impact

• Shareholders: The increased stake by a major insider could instill greater confidence in the company's future performance and strategic direction.

Key Dates

Recommendation

Keywords

REED'S INC, REED, Era Regenerative Medicine, D&D Source of Life Holding, Form 4, beneficial ownership, insider trading, PIPE, private equity, common stock, warrants, share acquisition